RS BioTherapeutics and National Institutes of Health Execute Research Collaboration Agreement to Evaluate Prevention and Treatment of Idiopathic Pulmonary Fibrosis
CUMBERLAND, Md., Aug. 29, 2023 (GLOBE NEWSWIRE) — RS BioTherapeutics, a life sciences company developing…
Scaling Smart: Strengthen Systems Before Expanding
ECCA and TTEC Release “Visionary Voices” Research on the Future of Contact Centre Sales in Europe